EVOK – Evoke Pharma Inc
Evoke Pharma, Inc.EVOK
$5.25Name : Evoke Pharma, Inc.
Sector : Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Mark. Cap: $4,301,178.00
EPSttm : -15.89
Evoke Pharma, Inc.
$5.25
0.96%$0.05Fair Value
Margin Of Safety %
Put/Call OI Ratio
Float Short %
8.87
EPS 1 Diff
EPS Year Diff
25.54
Ticker: EVOK
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2024-09-06 | EVOK | 3.78 | N/A | N/A | 0 |
| 2024-09-09 | EVOK | 4 | N/A | N/A | 0 |
| 2024-09-10 | EVOK | 4.09 | N/A | N/A | 0 |
| 2024-09-11 | EVOK | 4.04 | N/A | N/A | 0 |
| 2024-09-12 | EVOK | 4.19 | N/A | N/A | 0 |
| 2024-09-13 | EVOK | 4.31 | N/A | N/A | 0 |
| 2024-09-16 | EVOK | 4.18 | N/A | N/A | 0 |
| 2024-09-17 | EVOK | 4.36 | N/A | N/A | 0 |
| 2024-09-18 | EVOK | 4.39 | N/A | N/A | 0 |
| 2024-09-19 | EVOK | 4.38 | N/A | N/A | 0 |
| 2024-09-20 | EVOK | 4.47 | N/A | N/A | 0 |
| 2024-09-23 | EVOK | 5.26 | N/A | N/A | 0 |
| 2024-09-24 | EVOK | 5.01 | N/A | N/A | 0 |
| 2024-09-25 | EVOK | 4.83 | N/A | N/A | 0 |
| 2024-09-26 | EVOK | 5.02 | N/A | N/A | 0 |
| 2024-09-27 | EVOK | 4.81 | N/A | N/A | 0 |
| 2024-09-30 | EVOK | 4.77 | N/A | N/A | 0 |
| 2024-10-01 | EVOK | 4.67 | N/A | N/A | 0 |
| 2024-10-02 | EVOK | 4.96 | N/A | N/A | 0 |
| 2024-10-03 | EVOK | 5.08 | N/A | N/A | 0 |
| 2024-10-04 | EVOK | 5.14 | N/A | N/A | 0 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2024-09-06 | EVOK | 3.87 | 93.8 | - | -2.42 |
| 2024-09-09 | EVOK | 3.94 | 93.8 | - | -2.42 |
| 2024-09-10 | EVOK | 4.10 | 93.8 | - | -2.42 |
| 2024-09-11 | EVOK | 4.17 | 93.8 | - | -2.42 |
| 2024-09-12 | EVOK | 4.18 | 93.8 | - | -2.42 |
| 2024-09-13 | EVOK | 4.30 | 93.8 | - | -2.42 |
| 2024-09-16 | EVOK | 4.23 | 93.8 | - | -2.42 |
| 2024-09-17 | EVOK | 4.21 | 93.8 | - | -2.42 |
| 2024-09-18 | EVOK | 4.40 | 93.8 | - | -2.42 |
| 2024-09-19 | EVOK | 4.49 | 93.8 | - | -2.42 |
| 2024-09-20 | EVOK | 4.46 | 93.8 | - | -2.42 |
| 2024-09-23 | EVOK | 5.14 | 93.8 | - | -2.42 |
| 2024-09-24 | EVOK | 5.16 | 93.8 | - | -2.42 |
| 2024-09-25 | EVOK | 4.87 | 93.8 | - | -2.42 |
| 2024-09-26 | EVOK | 5.08 | 93.8 | - | -2.42 |
| 2024-09-27 | EVOK | 4.81 | 93.8 | - | -2.42 |
| 2024-09-30 | EVOK | 4.88 | 93.8 | - | -2.42 |
| 2024-10-01 | EVOK | 4.75 | 93.8 | - | -2.42 |
| 2024-10-02 | EVOK | 5.05 | 93.8 | - | -2.42 |
| 2024-10-03 | EVOK | 5.24 | 93.8 | - | -2.42 |
| 2024-10-04 | EVOK | 5.49 | 93.8 | - | -2.42 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2024-09-06 | EVOK | 0.00 | 0 | 0.46 |
| 2024-09-09 | EVOK | 0.00 | -36.55 | 0.46 |
| 2024-09-10 | EVOK | 0.00 | -36.55 | 0.46 |
| 2024-09-11 | EVOK | 0.00 | -36.55 | 0.46 |
| 2024-09-12 | EVOK | 0.00 | -36.55 | 10.46 |
| 2024-09-13 | EVOK | 0.00 | -36.55 | 10.46 |
| 2024-09-16 | EVOK | 0.00 | -36.69 | 10.46 |
| 2024-09-17 | EVOK | 0.00 | -36.69 | 10.46 |
| 2024-09-18 | EVOK | 0.00 | -36.69 | 10.46 |
| 2024-09-19 | EVOK | 0.00 | -36.69 | 10.46 |
| 2024-09-20 | EVOK | 0.00 | -36.69 | 10.46 |
| 2024-09-23 | EVOK | 0.00 | -36.43 | 10.46 |
| 2024-09-24 | EVOK | 0.00 | -36.43 | 10.46 |
| 2024-09-25 | EVOK | 0.00 | -36.43 | 8.87 |
| 2024-09-26 | EVOK | 0.00 | -36.43 | 8.87 |
| 2024-09-27 | EVOK | 0.00 | -36.43 | 8.87 |
| 2024-09-30 | EVOK | 0.00 | -36.86 | 8.87 |
| 2024-10-01 | EVOK | 0.00 | -36.86 | 8.87 |
| 2024-10-02 | EVOK | 0.00 | -36.86 | 8.87 |
| 2024-10-03 | EVOK | 0.00 | -36.86 | 8.87 |
| 2024-10-04 | EVOK | 0.00 | -36.86 | 8.87 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
-0.38
Avg. EPS Est. Next Quarter
-0.25
Insider Transactions
Institutional Transactions
-36.86
Beta
0.37
Average Sales Estimate Current Quarter
3
Average Sales Estimate Next Quarter
3
Fair Value (Academic)
Quality Score
32
Growth Score
42
Sentiment Score
45
Actual DrawDown %
99.4
Max Drawdown 5-Year %
-99.5
Target Price
18
P/E
Forward P/E
21.88
PEG
P/S
0.57
P/B
1.45
P/Free Cash Flow
EPS
-16.23
Average EPS Est. Cur. Y
-2.42
EPS Next Y. (Est.)
0.24
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-86.75
Relative Volume
3.18
Return on Equity vs Sector %
-266.6
Return on Equity vs Industry %
-256.9
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
Evoke Pharma, Inc.Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 4
Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.
stock quote shares EVOK – Evoke Pharma Inc Stock Price stock today
news today EVOK – Evoke Pharma Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch EVOK – Evoke Pharma Inc yahoo finance google finance
stock history EVOK – Evoke Pharma Inc invest stock market
stock prices EVOK premarket after hours
ticker EVOK fair value insiders trading